Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease.

Janelle Vu Pugashetti, Dinesh Khanna, Ella A Kazerooni, Justin Oldham

Immunology and allergy clinics of North America 2023 May

filter terms:

Interstitial lung disease (ILD) complicates connective tissue disease (CTD) with variable incidence and is a leading cause of death in these patients. To improve CTD-ILD outcomes, early recognition and management of ILD is critical. Blood-based and radiologic biomarkers that assist in the diagnosis CTD-ILD have long been studied. Recent studies, including -omic investigations, have also begun to identify biomarkers that may help prognosticate such patients. This review provides an overview of clinically relevant biomarkers in patients with CTD-ILD, highlighting recent advances to assist in the diagnosis and prognostication of CTD-ILD. Published by Elsevier Inc.

Citation

Janelle Vu Pugashetti, Dinesh Khanna, Ella A Kazerooni, Justin Oldham. Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease. Immunology and allergy clinics of North America. 2023 May;43(2):411-433